Entities / Company
Harvard Bioscience.
company in Holliston, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
MarketBeat reports consensus rating for Harvard Bioscience, which is listed on Nasdaq. Benchmark has boosted its target price for the company's stock.Some support2 reports
-
Harvard Bioscience is facing revenue decline due to macro uncertainty over tariffs and ongoing issues regarding NIH funding.Some support1 report1 development inside
-
John Duke is the President and CEO of Harvard Bioscience, which is currently managing sales weighted toward lower-margin products in China.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Harvard Bioscience this week
News at the entities that move Harvard Bioscience most-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Harvard Bioscience
-
Benchmark TransactionalMarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.Moves Harvard Bioscience
-
MarketBeat Mentioned togetherMarketBeat aggregates data on IDT Corporation stock performance.Moves Harvard Bioscience
-
China Shared contextThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves Harvard Bioscience
Connections
The 5 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
John Duke Structural
John Duke serves as the President and CEO of Harvard Bioscience, having previously been appointed to the board of directors.
-
Nasdaq Structural
Harvard Bioscience is a publicly listed company trading on the Nasdaq stock exchange.
-
MarketBeat Mentioned together
MarketBeat provides consensus ratings and coverage for Harvard Bioscience.
-
China Shared context
Harvard Bioscience maintains operations and sales presence within the Chinese market.
-
Benchmark Transactional
Benchmark raised its target price for Harvard Bioscience stock.